Targeting miR-185-3p Inhibits Head and Neck Squamous Cell Carcinoma by Modulating RAB25

Código QR

Targeting miR-185-3p Inhibits Head and Neck Squamous Cell Carcinoma by Modulating RAB25

Cancer cell-derived exosomes regulate tumor growth and progression. However, the effects of exosomes and its contents on head and neck squamous cell carcinoma (HNSCC) and its underlying mechanisms remain unclear. Here, we found HNSCC displayed a dysregulation of exosomes biogenesis. miR-185-3p was o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xueping Wang, Xiaoyuan Zhu, Yulin Zhao
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	head and neck squamous cell carcinoma exosome miR-185-3p RAB25 tumor growth Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/d4db6a0c26f044419283560f93007039
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Hidden Link of Exosomes to Head and Neck Cancer
por: Yong Teng, et al.
Publicado: (2021)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
por: Farzaneh Kordbacheh, et al.
Publicado: (2021)

OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer
por: Min-Ying Lin, et al.
Publicado: (2021)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
por: Fu L, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
por: Philipp Baumeister, et al.
Publicado: (2021)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Xinwen Wang, et al.
Publicado: (2021)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi N, et al.
Publicado: (2021)

New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas
por: Cristina Porcheri, et al.
Publicado: (2021)

Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
por: Galo Méndez-Matías, et al.
Publicado: (2021)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
por: Karl Payne, et al.
Publicado: (2021)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xuanli Xu, et al.
Publicado: (2021)

miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2
por: Değerli,Elif, et al.
Publicado: (2020)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
por: Lucrezia Togni, et al.
Publicado: (2021)

Indian journal of otolaryngology and head and neck surgery official publication of the Association of Otolaryngologists of India.
Publicado: (1993)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
por: Pei-Hung Chang, et al.
Publicado: (2021)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Ying-Peng Peng, et al.
Publicado: (2021)

Imaging Features of Postradiotherapy Changes in Head and Neck Cancers
por: Anisha Gehani, et al.
Publicado: (2021)

The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth
por: Hassan CE, et al.
Publicado: (2016)

MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma
por: Shine-Gwo Shiah, et al.
Publicado: (2021)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
por: Qian X, et al.
Publicado: (2021)

Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma
por: Song C, et al.
Publicado: (2020)

A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma
por: Xiaolei Gao, et al.
Publicado: (2021)

MiR-140 inhibits classical swine fever virus replication by targeting Rab25 in swine umbilical vein endothelial cells
por: Panpan Xu, et al.
Publicado: (2020)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Shinsuke Suzuki, et al.
Publicado: (2021)

Oral and Oropharyngeal Squamous Cell Carcinoma in Our Population: The Clinic-Pathological and Morphological Description of 153 Cases
por: Agarwal,A. K, et al.
Publicado: (2011)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
por: Ammar Sukari, et al.
Publicado: (2015)

A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
por: Re-I Chin, et al.
Publicado: (2021)

Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
por: Adam Luginbuhl, et al.
Publicado: (2021)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
por: Xing-xing Huo, et al.
Publicado: (2021)

Associations between dynamic-contrast enhanced MRI and tumor infiltrating lymphocytes and tumor-stroma ratio in head and neck squamous cell cancer
por: Hans-Jonas Meyer, et al.
Publicado: (2021)

PSYCHIATRIC MORBIDITY AND ASSOCIATED SOCIO-DEMOGRAPHIC FACTORS AMONG THE PATIENTS OF HEAD AND NECK TUMORS
por: Usama Bin Zubair, et al.
Publicado: (2019)

Roles of mesenchymal stromal cells in the head and neck cancer microenvironment
por: Marcelo Coutinho de Miranda, et al.
Publicado: (2021)

The endocytic pathway taken by cationic substances requires Rab14 but not Rab5 and Rab7
por: Evgeniya Trofimenko, et al.
Publicado: (2021)

Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?
por: Iago Ferreira, et al.
Publicado: (2021)

Effects of miR-185-5p on replication of hepatitis C virus
por: Huang Wei, et al.
Publicado: (2021)

Treatment Outcomes and the Safety of Chemoradiotherapy With High-Dose CDDP for Elderly Patients With Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Study
por: Jo Omata, et al.
Publicado: (2021)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
por: Jerry Polesel, et al.
Publicado: (2021)

Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
por: He Jian, et al.
Publicado: (2021)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Joanna Kozłowska, et al.
Publicado: (2020)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qi Sun, et al.
Publicado: (2021)